GLP-1 Tax Deduction 2026: What Self-Employed USA LLC Owners Need to Know

GLP-1 tax deduction 2026 rules can help LLC owners manage high medication costs. This includes prescriptions such as semaglutide or tirzepatide. For any LLC owner GLP-1 deduction strategy, you need to understand IRS GLP-1 deduction rules first. Health insurance, HSA planning, and tax deductions for GLP-1s may all affect your final savings.

Why GLP-1 Tax Deductions Matter for Self-Employed LLC Owners in 2026

Monthly pharmacotherapy costs for GLP-1 medications hit hard. Wegovy or Ozempic can exceed $900 per month without coverage, while compounded versions of semaglutide or tirzepatide typically land between $150 and $350 monthly. That's a significant annual expense, and for LLC owners, the tax code offers options that W-2 employees simply don't have.

Self-employed individuals sit at a unique intersection of small business tax planning and personal health costs. That makes GLP-1 costs self-employed workers pay an important part of yearly tax planning. Three deduction pathways are available: deducting health insurance premiums above the line, claiming GLP-1 costs as itemized medical expenses, and using a health savings account funded with pre-tax dollars. Knowing which path fits your situation can meaningfully change what you actually pay.

When the IRS Allows GLP-1 Deductions: Medical Necessity vs. Cosmetic Use

The IRS draws a clear line here. GLP-1 medications qualify as deductible expenses only when a physician prescribes them to diagnose, treat, mitigate, cure, or prevent a specific disease. Examples may include physician-diagnosed obesity, hypertension, heart disease, Type 2 diabetes, or another diagnosed condition for which the prescription is medically necessary.

Using a GLP-1 solely for cosmetic weight loss, without a formal medical diagnosis, disqualifies the expense entirely. That distinction matters more than people expect. Documentation is your protection: keep the physician's prescription, the formal diagnosis in writing, and a letter of medical necessity.

Without those records, the IRS has grounds to deny the deduction on audit. Compounded versions of semaglutide or tirzepatide follow the same IRS code rules as brand-name drugs like Mounjaro or Zepbound, provided the prescription and diagnosis are properly documented.

Self-Employed Health Insurance Premiums: The Above-the-Line Deduction

LLC owners can deduct 100% of health insurance premiums for themselves, their spouse, and their dependents as an above-the-line adjustment on Schedule 1 of Form 1040. This directly reduces adjusted gross income, which matters because a lower AGI makes the 7.5% medical expense threshold easier to clear later.

Two conditions apply: the business must show net profit, and the owner can't be eligible for an employer-sponsored plan through a spouse's job. This is the self-employed health insurance deduction LLC owners often overlook when they're focused on Schedule C business expenses. This health insurance premium deduction can reduce AGI, but it does not turn medication purchases into premium costs.

A crucial distinction is that this deduction covers premiums only. The cost of GLP-1 medications themselves is a separate category, treated as a qualified medical expense rather than a premium. S-corp owners work through a slightly different process, where the corporation deducts the premiums and includes them in the shareholder's W-2 wages, and the shareholder then takes the deduction on Schedule 1. The end result is similar, but the paperwork path differs. Some S-corp owners may also discuss an accountable plan with a tax professional, but the correct setup depends on the business structure.

The 7.5% AGI Threshold: Making Itemized Medical Deductions Work

GLP-1 costs qualify as medical expenses on Schedule A, but there's a catch. Only the portion of your total unreimbursed medical expenses that exceeds 7.5% of your AGI is actually deductible. This medical expense deduction 2026 rule matters most when GLP-1 costs are combined with other deductible expenses. At an $80,000 AGI, that threshold sits at $6,000. If your out-of-pocket GLP-1 costs total $4,000 for the year, you get no deduction from those costs alone.

Here is how the 7.5% AGI threshold can change the deductible amount:

The math becomes more favorable when GLP-1 costs are combined with other significant medical expenses. Despite this, many taxpayers take the standard deduction, so claiming a Schedule A medical deduction may not help unless total itemized deductions are high enough.

One rule applies without exception: only unreimbursed, out-of-pocket costs count. Any amount you paid using HSA or FSA funds can't be deducted again on Schedule A. Double-dipping isn't allowed, and the IRS watches for it.

Health Savings Accounts: The Triple Tax Advantage for GLP-1 Users

For most self-employed GLP-1 users, the health savings account strategy beats the itemized deduction route. The HSA's tax structure is genuinely hard to beat: contributions are tax-deductible, the account grows tax-free, and qualified withdrawals (including GLP-1 medication costs) come out tax-free. That's three separate tax benefits from one account.

For 2026, HSA contribution limits are $4,400 for self-only HDHP coverage and $8,750 for family HDHP coverage. GLP-1 medications, including compounded semaglutide and tirzepatide products like Ozempic or Mounjaro, are qualified HSA expenses when prescribed for a diagnosed condition.

Prescription medication costs may qualify only when they meet IRS medical expense rules. Compounded GLP-1 products also require extra caution because compounded drugs are not FDA-approved, and their safety, effectiveness, and quality are not verified by FDA before marketing.

The requirement is enrollment in a High-Deductible Health Plan (HDHP). For GLP-1 users paying significant out-of-pocket costs, HDHPs often make sense anyway: lower monthly premiums offset some of the medication cost, and the HSA access covers the rest with pre-tax dollars. Flexible spending accounts (FSAs) work similarly for those who don't have HDHP coverage, though FSAs carry use-it-or-lose-it rules that HSAs don't.

2026 Updates: Medicare GLP-1 Bridge and Marketplace Coverage Shifts

A few notable changes affect the GLP-1 tax deduction 2026 picture. Medicare is temporarily covering GLP-1 medications for obesity treatment through a program called the "Medicare GLP-1 Bridge," running from July 1, 2026, through December 31, 2027, for eligible Medicare Part D beneficiaries. For eligible beneficiaries, that coverage changes the "unreimbursed" calculation, since costs covered by Medicare no longer qualify as out-of-pocket expenses for deduction purposes.

On the Affordable Care Act marketplace side, states including California, New York, and Massachusetts have moved toward broader coverage for obesity medications in 2025 and 2026. Most marketplace plans still exclude them, though that's slowly shifting.

The core IRS rules for medical expense deductions aren't expected to change in 2026. The 7.5% AGI threshold stays in place, and the medical necessity requirement remains firm. For small business owners doing tax planning now, the HSA contribution limit increases are the most actionable update, since those limits reset each year and unused contribution room doesn't carry forward.

Bottom Line: Plan GLP-1 Tax Savings Carefully in 2026

GLP-1 tax deductions can help self-employed LLC owners, but only when the prescription is tied to a documented medical need. Keep your prescription, diagnosis proof, receipts, and HSA or FSA records organized.

If insurance does not cover the full cost, you may also compare licensed Canadian pharmacy options, such as Polar Bear Meds. Before claiming any deduction, confirm your eligibility with a qualified tax professional.